Antibodies against il-17br

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/28 (2006.01) A61K 39/395 (2006.01) C12N 5/12 (2006.01) C12N 15/13 (2006.01)

Patent

CA 2757104

The invention provides the antibody D9.2 and antibody molecules based on D9.2 which bind interleukin-17 receptor B. These may be useful in therapy, e.g. the treatment of asthma, ulcerative colitis or Crohn's disease.

L'invention porte sur un anticorps D9.2 et sur des molécules d'anticorps basées sur D9.2 qui se lient au récepteur B de l'interleukine 17. Ceux-ci peuvent être utiles en thérapie, par exemple dans le traitement de l'asthme, d'une colite ulcéreuse ou de la maladie de Crohn.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antibodies against il-17br does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies against il-17br, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies against il-17br will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1752618

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.